Breast Imaging

Lancet Oncology: Global breast cancer cases could surge to 3.5M by 2050
By Kate Madden Yee
The study also found that yearly deaths could increase by 44%, climbing from 764,000 in 2023 to nearly 1.4 million in 2050.
March 3, 2026
Graph Arrow Up 400
Mammography screening improves survival for late-stage cancers
By Amerigo Allegretto
Women with screen-detected late-stage cancer have greater survival compared with women who do not undergo mammography screening.
February 23, 2026
Mammogram Dense Breasts Cropped
German team unveils dose findings on breast MRI
By Kate Madden Yee
Breast MRI using gadopiclenol with a half gadolinium dose offers equivalent to superior contrast enhancement compared to gadobutrol-enhanced MRI with full gadolinium dose.
February 9, 2026
Mri Breast Cancer
Audit puts spotlight on breast density in women under 50
By Philip Ward
A 12-year audit conducted at a women’s imaging facility has provided new data on the link between mammographic breast density and cancer detection in younger patients.
February 5, 2026
Right breast, 10 o’clock position, same patient: A 15 mm irregular hypoechoic solid lesion with suspicious morphology, situated approximately 6 mm from the index lesion. Biopsy confirmed invasive ductal carcinoma, Grade 2, ER positive, PR positive, HER2 positive, concordant with ultrasound features. Findings are in keeping with multifocal invasive ductal carcinoma in a heterogeneously dense breast. The patient was referred for surgical management.
DBT shows advantages over mammography in TMIST Lead-in analysis
By Amerigo Allegretto
DBT could improve screening performance over conventional mammography in age groups not eligible for the TMIST study.
February 4, 2026
Breast Tomosynthesis Digital Social
QT Imaging, Olea Medical partner on multimodal breast imaging
By AuntMinnieEurope.com staff writers
Olea Medical's technology will be integrated with QT Imaging's breast imaging platform as QT Imaging Olea Vision software.
February 2, 2026
Breast Imaging Computer Screen Thumbnail
AI-mammography finds more interval cancers, cuts workload
By Amerigo Allegretto
AI-supported mammography leads to more positive outcomes for women compared with standard double reading, a new European study has found.
January 30, 2026
Breast Mammo Computer
ESR reveals plans for 3 organ-based scientific journals
By Liz Carey
The European Society of Radiology (ESR) is moving ahead with plans to publish three new organ-based spinoff scientific journals.
January 26, 2026
Thumb For Ecr 2025 Attendance Figs
Italy issues guidelines on how to use breast AI
By AuntMinnieEurope.com staff writers
New guidelines jointly developed by multiple Italian medical societies call for AI to decide which mammograms should go to single or double reading by radiologists.
January 23, 2026
Italian Flag 400
Attention turns to value of AI updates in breast screening
By Maryam Payne
A research group from Oslo has found that the net clinical benefit of using updated versions of AI in breast screening remains unknown.
January 19, 2026
Left craniocaudal and mediolateral oblique mammograms in a 53-year-old woman with an invasive 4-mm histologic grade 1 screen-detected cancer. The exam-level AI score for v1.7 was 5 and 10 for v2.1 (increased AI score). The red circles mark the location of the tumor.
International team pinpoints causes of missed breast cancers
By Maryam Payne
The key factors that contribute to diagnostic errors in mammography have come under close scrutiny. The authors present a series of insightful clinical cases.
January 12, 2026
(a) Mediolateral oblique and craniocaudal screening mammograms in a 52-year-old woman demonstrated an isodense focal asymmetry in the lower inner right breast, projected over the retromammary fat (red arrows). This finding was not reported by the first reader, likely due to its location at the periphery of the image, and was reported by the second reader. Assessment with ultrasound (not shown) was unremarkable. (b) Breast MRI was subsequently performed, and the axial maximum intensity projection image revealed an irregular enhancing mass in the lower right breast, corresponding to the mammographic asymmetry (yellow arrows). Axial image obtained during MRI-guided biopsy, which revealed histopathology of grade 2 invasive lobular carcinoma.
CEM is a reliable tool for evaluating screening recalls
By Amerigo Allegretto
Italian researchers have shown that contrast-enhanced mammography (CEM) can accurately evaluate recalled screening mammograms.
January 8, 2026
2024 10 18 Mammography Comparison Clinical Images Thumbnail
Page 1 of 141
Next Page